Aug 13 (Reuters) - ImmunoCellular Therapeutics Ltd :
* IMMUNOCELLULAR THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS
* Q2 LOSS PER SHARE $0.01
* ONGOING EXPLORATION OF STRATEGIC OPPORTUNITIES
* CONTINUED PROGRESS IN STEM-TO-T-CELL PROGRAM
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* IMMUNOCELLULAR THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS
* Q2 LOSS PER SHARE $0.01
* ONGOING EXPLORATION OF STRATEGIC OPPORTUNITIES
* CONTINUED PROGRESS IN STEM-TO-T-CELL PROGRAM
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)